Silver Book Fact

The rate of hospitalization from heart failure before and after transcatheter mitral valve repair (TMVR) decreases 73% (per patient year) in patients at prohibitive surgical risk.

Lim D, Reynolds M, Feldman T, Kar S, et al. Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair. J Am Coll Cardiol. 2014; 64(2). https://www.ncbi.nlm.nih.gov/pubmed/24184254

Reference

Title
Improved Functional Status and Quality of Life in Prohibitive Surgical Risk Patients with Degenerative Mitral Regurgitation After Transcatheter Mitral Valve Repair
Publication
J Am Coll Cardiol
Publication Date
2014
Authors
Lim D, Reynolds M, Feldman T, Kar S, et al.
Volume & Issue
Volume 64, Issue 2
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Between 1998 and 2008, the rate of death attributable to cardiovascular disease declined 30.6%.  
  • Major cardiovascular event rates could be reduced by 80% simply by acting on known risk factors with therapies already shown to be effective.  
  • If all forms of cardiovascular disease were eliminated, life expectancy would rise by almost 7 years.  
  • 5 years of treatment with beta-blockers for heart failure increases patient survival by about 3 1/2 months and patients had fewer overnight hospital stays.  
  • Trends in carotid endarterectomy procedures